Publications
Discover how our technologies have been applied
Our technologies and bioinformatics workflows have been used to obtain deep insights into different aspects of RNA biology, and our own scientific team frequently publishes on our newest capabilities. The following publications provide some examples of how our partners have utilized our capabilities to make groundbreaking discoveries. Contact us today to learn how we can help you achieve your therapeutic and research goals.
Contact usNUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia.
Witkowski et al. Nature Communications
miR-486 is essential for muscle function and suppresses a dystrophic transcriptome.
Samani et al. Life Science Alliance
A functional screen of RNA binding proteins identifies genes that promote or limit the accumulation of CD138+ plasma cells.
Turner et al. eLife.
The Musashi proteins are post-transcriptional activators of protein expression and alternative exon splicing in vertebrate photoreceptors.
Matalkah et al. BioRxiv
Functional genomics of RAP proteins and their role in mitoribosome regulation in Plasmodium falciparum.
Hollin et al. Nature Communications
Genomewide m6A mapping uncovers dynamic changes in the m6A epitranscriptome of cisplatin-treated apoptotic HeLa cells.
Akçaöz Alasar et al. Cells